<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00003637</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000066722</org_study_id>
    <secondary_id>NMRC-SQNP01</secondary_id>
    <secondary_id>EU-98047</secondary_id>
    <nct_id>NCT00003637</nct_id>
  </id_info>
  <brief_title>Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx</brief_title>
  <official_title>Standard Radiotherapy Versus Concurrent Chemo-Radiotherapy Followed by Adjuvant Chemotherapy for Locally Advanced (Non-Metastatic) Nasopharyngeal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Centre, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in&#xD;
      chemotherapy use different ways to stop tumor cells from dividing so they stop growing or&#xD;
      die. It is not yet known whether radiation therapy alone is more effective than radiation&#xD;
      therapy plus chemotherapy in treating cancer of the nasopharynx.&#xD;
&#xD;
      PURPOSE: This randomized phase III trial is studying how well radiation therapy and&#xD;
      chemotherapy works compared to radiation therapy alone in treating patients with previously&#xD;
      untreated cancer of the nasopharynx.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  Compare the clinical response, distant metastases, disease-free survival, and overall&#xD;
           survival in patients with previously untreated, locally advanced, nonmetastatic&#xD;
           nasopharyngeal cancer treated with radiotherapy alone vs concurrent chemoradiotherapy&#xD;
           followed by adjuvant chemotherapy.&#xD;
&#xD;
      OUTLINE: This is a randomized study.&#xD;
&#xD;
      Patients are randomized to receive radiotherapy alone (arm I) or concurrent chemoradiotherapy&#xD;
      followed by adjuvant chemotherapy (arm II).&#xD;
&#xD;
        -  Arm I: Patients receive radiotherapy once daily 5 times a week for 7 weeks.&#xD;
&#xD;
        -  Arm II: Patients receive cisplatin IV over 6-8 hours for 4 consecutive days every 3&#xD;
           weeks for 3 courses. Concurrent radiotherapy is given once daily 5 times a week over the&#xD;
           7 week treatment period. This chemoradiotherapy is followed 3 weeks later by adjuvant&#xD;
           chemotherapy. Patients receive cisplatin IV and fluorouracil IV over 6-8 hours for 4&#xD;
           consecutive days every 4 weeks for 3 courses.&#xD;
&#xD;
      Patients are followed every 4 months for the first year, every 6 months for the next 2 years,&#xD;
      and then annually thereafter until death.&#xD;
&#xD;
      PROJECTED ACCRUAL: A minimum of 200 patients will be accrued for this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 1998</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical response</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Distant metastases</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease-free survival</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival</measure>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Head and Neck Cancer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cisplatin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fluorouracil</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Histologically confirmed nasopharyngeal cancer that is previously untreated WHO Type&#xD;
             III&#xD;
&#xD;
          -  Stage III/IV (T3-4 Nx M0 or Tx N2-3 M0) confirmed by CT PNS&#xD;
&#xD;
          -  No evidence of distant metastases detected on chest x-ray, bone scan, and liver&#xD;
             ultrasound&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Age:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Performance status:&#xD;
&#xD;
          -  ECOG 0-1&#xD;
&#xD;
        Life expectancy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hematopoietic:&#xD;
&#xD;
          -  WBC greater than 3,000/mm^3&#xD;
&#xD;
          -  Platelet count greater than 100,000/mm^3&#xD;
&#xD;
        Hepatic:&#xD;
&#xD;
          -  SAP and SGOT less than 2 times upper limit of normal&#xD;
&#xD;
          -  Bilirubin less than 1.4 mg/dL&#xD;
&#xD;
        Renal:&#xD;
&#xD;
          -  Creatinine less than 1.6 mg/dL&#xD;
&#xD;
          -  Creatinine clearance greater than 50 mL/min&#xD;
&#xD;
        Other:&#xD;
&#xD;
          -  No other malignant disease&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
        Biologic therapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Chemotherapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Endocrine therapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Radiotherapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Surgery&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Other&#xD;
&#xD;
          -  See Disease Characteristics&#xD;
&#xD;
          -  No concurrent aminoglycoside antibiotics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eu J. Chua, MD</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Centre, Singapore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Cancer Centre - Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169610</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>January 2006</verification_date>
  <study_first_submitted>November 1, 1999</study_first_submitted>
  <study_first_submitted_qc>January 26, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2003</study_first_posted>
  <last_update_submitted>December 18, 2013</last_update_submitted>
  <last_update_submitted_qc>December 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2013</last_update_posted>
  <keyword>stage III lymphoepithelioma of the nasopharynx</keyword>
  <keyword>stage IV squamous cell carcinoma of the nasopharynx</keyword>
  <keyword>stage III squamous cell carcinoma of the nasopharynx</keyword>
  <keyword>stage IV lymphoepithelioma of the nasopharynx</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cisplatin</mesh_term>
    <mesh_term>Fluorouracil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

